Cambridge Investment Research Advisors’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $472K | Buy |
23,030
+3,233
| +16% | +$66.3K | ﹤0.01% | 2598 |
|
|
2025
Q1 | $406K | Buy |
19,797
+756
| +4% | +$15.5K | ﹤0.01% | 2628 |
|
|
2024
Q4 | $431K | Buy |
19,041
+7,703
| +68% | +$174K | ﹤0.01% | 2552 |
|
|
2024
Q3 | $279K | Sell |
11,338
-88
| -0.8% | -$2.17K | ﹤0.01% | 2883 |
|
|
2024
Q2 | $264K | Buy |
11,426
+1,875
| +20% | +$43.3K | ﹤0.01% | 2808 |
|
|
2024
Q1 | $230K | Sell |
9,551
-19,200
| -67% | -$462K | ﹤0.01% | 2910 |
|
|
2023
Q4 | $662K | Sell |
28,751
-3,580
| -11% | -$82.4K | ﹤0.01% | 1963 |
|
|
2023
Q3 | $658K | Buy |
32,331
+227
| +0.7% | +$4.62K | ﹤0.01% | 1859 |
|
|
2023
Q2 | $750K | Buy |
32,104
+1,948
| +6% | +$45.5K | ﹤0.01% | 1819 |
|
|
2023
Q1 | $702K | Buy |
30,156
+577
| +2% | +$13.4K | ﹤0.01% | 1825 |
|
|
2022
Q4 | $745K | Buy |
29,579
+627
| +2% | +$15.8K | ﹤0.01% | 1723 |
|
|
2022
Q3 | $764K | Sell |
28,952
-3,779
| -12% | -$99.7K | ﹤0.01% | 1659 |
|
|
2022
Q2 | $946K | Buy |
32,731
+11,671
| +55% | +$337K | 0.01% | 1518 |
|
|
2022
Q1 | $726K | Sell |
21,060
-3,196
| -13% | -$110K | ﹤0.01% | 1812 |
|
|
2021
Q4 | $1.06M | Buy |
24,256
+1,483
| +7% | +$65K | ﹤0.01% | 1538 |
|
|
2021
Q3 | $1.16M | Sell |
22,773
-450
| -2% | -$22.8K | 0.01% | 1420 |
|
|
2021
Q2 | $1.21M | Sell |
23,223
-144
| -0.6% | -$7.49K | 0.01% | 1396 |
|
|
2021
Q1 | $1.07M | Buy |
23,367
+786
| +3% | +$35.9K | 0.01% | 1397 |
|
|
2020
Q4 | $1.04M | Buy |
22,581
+1,945
| +9% | +$89.3K | 0.01% | 1282 |
|
|
2020
Q3 | $804K | Buy |
20,636
+4,892
| +31% | +$191K | 0.01% | 1310 |
|
|
2020
Q2 | $598K | Buy |
+15,744
| New | +$598K | ﹤0.01% | 1456 |
|